Literature DB >> 19609923

Epistatic interactions govern chemically-induced lung tumor susceptibility and Kras mutation site in murine C57BL/6J-ChrA/J chromosome substitution strains.

Lori D Dwyer-Nield1, Jay McQuillan, Annie Hill-Baskin, Richard A Radcliffe, Ming You, Joseph H Nadeau, Alvin M Malkinson.   

Abstract

Cancer susceptibility results from interactions between sensitivity and resistance alleles. We employed murine chromosome substitution strains to study how resistance alleles affected sensitive alleles during chemically-induced lung carcinogenesis. The C57BL/6J-Chr#(A/J) strains, constructed by selectively breeding sensitive A/J and resistant C57BL/6J (B6) mice, each contain one pair of A/J chromosomes within an otherwise B6 genome. Pas1, the major locus responsible for this differential strain response to urethane carcinogenesis, resides on Chr 6, but C57BL/6J-Chr6(A/J) mice (hereafter CSS-6) developed few tumors following a single urethane injection, which demonstrates epistatic interactions with other B6 alleles. CSS6 mice developed dozens of lung tumors after chronic urethane exposure, however, indicating that these epistatic interactions could be overcome by repeated carcinogen administration. Unlike A/J, but similar to B6 mice, CSS6 mice were resistant to lung carcinogenesis induced by 3-methylcholanthrene (MCA). Tumor multiplicity increased if BHT administration followed urethane exposure, showing that a Chr 6 gene(s) regulates sensitivity to chemically-induced tumor promotion. Unlike A/J tumors (predominantly codon 61 A-->T transversions), Kras mutations in tumors induced by urethane in CSS-6 mice were similar to B6 tumors (codon 61 A-->G transitions). DNA repair genes not located on Chr 6 may determine the nature of Kras mutations. CSS-6 mice are a valuable resource for testing the ability of candidate genes to modulate lung carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19609923      PMCID: PMC2783521          DOI: 10.1002/ijc.24743

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  43 in total

1.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

2.  Differences in KRAS mutation spectrum in lung cancer cases between African Americans and Caucasians after occupational or environmental exposure to known carcinogens.

Authors:  Jay D Hunt; Anna Strimas; Julie E Martin; Marilyn Eyer; Monica Haddican; Brian G Luckett; Bernardo Ruiz; T William Axelrad; Wayne L Backes; Elizabeth T H Fontham
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-11       Impact factor: 4.254

Review 3.  Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung.

Authors:  A M Malkinson
Journal:  Lung Cancer       Date:  2001-06       Impact factor: 5.705

4.  Multiple trait measurements in 43 inbred mouse strains capture the phenotypic diversity characteristic of human populations.

Authors:  Karen L Svenson; Randy Von Smith; Phyllis A Magnani; Heather R Suetin; Beverly Paigen; Jürgen K Naggert; Renhua Li; Gary A Churchill; Luanne L Peters
Journal:  J Appl Physiol (1985)       Date:  2007-02-22

5.  Prognostic value of specific KRAS mutations in lung adenocarcinomas.

Authors:  J M Siegfried; A T Gillespie; R Mera; T J Casey; P Keohavong; J R Testa; J D Hunt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-10       Impact factor: 4.254

6.  Carrier detection in the Wiskott Aldrich syndrome.

Authors:  E R Fearon; D B Kohn; J A Winkelstein; B Vogelstein; R M Blaese
Journal:  Blood       Date:  1988-11       Impact factor: 22.113

7.  Major effect on susceptibility to urethan-induced pulmonary adenoma by a single gene in BALB/cBy mice.

Authors:  A M Malkinson; D S Beer
Journal:  J Natl Cancer Inst       Date:  1983-05       Impact factor: 13.506

8.  Enhancement of urethan tumorigenesis in mouse lung by butylated hydroxytoluene.

Authors:  H Witschi; D Williamson; S Lock
Journal:  J Natl Cancer Inst       Date:  1977-02       Impact factor: 13.506

9.  Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene.

Authors:  L Lin; M F Festing; T R Devereux; K A Crist; S C Christiansen; Y Wang; A Yang; K Svenson; B Paigen; A M Malkinson; M You
Journal:  Exp Lung Res       Date:  1998 Jul-Aug       Impact factor: 2.459

10.  Pharmacologic and genetic studies on the modulatory effects of butylated hydroxytoluene on mouse lung adenoma formation.

Authors:  A M Malkinson; D S Beer
Journal:  J Natl Cancer Inst       Date:  1984-10       Impact factor: 13.506

View more
  9 in total

1.  Immune Surveillance by Natural IgM Is Required for Early Neoantigen Recognition and Initiation of Adaptive Immunity.

Authors:  Shaikh M Atif; Sophie L Gibbings; Elizabeth F Redente; Faye A Camp; Raul M Torres; Ross M Kedl; Peter M Henson; Claudia V Jakubzick
Journal:  Am J Respir Cell Mol Biol       Date:  2018-11       Impact factor: 6.914

2.  The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance.

Authors:  Annalisa Del Prete; Francesca Sozio; Tiziana Schioppa; Andrea Ponzetta; William Vermi; Stefano Calza; Mattia Bugatti; Valentina Salvi; Giovanni Bernardini; Federica Benvenuti; Annunciata Vecchi; Barbara Bottazzi; Alberto Mantovani; Silvano Sozzani
Journal:  Cancer Immunol Res       Date:  2019-09-04       Impact factor: 11.151

3.  WeSME: uncovering mutual exclusivity of cancer drivers and beyond.

Authors:  Yoo-Ah Kim; Sanna Madan; Teresa M Przytycka
Journal:  Bioinformatics       Date:  2017-03-15       Impact factor: 6.937

4.  Rare codons capacitate Kras-driven de novo tumorigenesis.

Authors:  Nicole L K Pershing; Benjamin L Lampson; Jason A Belsky; Erin Kaltenbrun; David M MacAlpine; Christopher M Counter
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

5.  The Kras mutational spectra of chemically induced lung tumors in different inbred mice mimics the spectra of KRAS mutations in adenocarcinomas in smokers versus nonsmokers.

Authors:  Jason M Fritz; Lori D Dwyer-Nield; Bridgette M Russell; Alvin M Malkinson
Journal:  J Thorac Oncol       Date:  2010-02       Impact factor: 15.609

6.  Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development.

Authors:  Stefanie B Marquez-Vilendrer; Sudhir K Rai; Sarah Jb Gramling; Li Lu; David N Reisman
Journal:  Oncoscience       Date:  2016-11-17

7.  Non-canonical genomic driver mutations of urethane carcinogenesis.

Authors:  Siqi Li; Christopher M Counter
Journal:  PLoS One       Date:  2022-04-28       Impact factor: 3.752

8.  Activation of liver X receptor inhibits the development of pulmonary carcinomas induced by 3-methylcholanthrene and butylated hydroxytoluene in BALB/c mice.

Authors:  Qixue Wang; Lei Sun; Xiaoxiao Yang; Xingzhe Ma; Qi Li; Yuanli Chen; Ying Liu; Di Zhang; Xiaoju Li; Rong Xiang; Yuquan Wei; Jihong Han; Yajun Duan
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379

9.  Capturing the primordial Kras mutation initiating urethane carcinogenesis.

Authors:  Siqi Li; David M MacAlpine; Christopher M Counter
Journal:  Nat Commun       Date:  2020-04-14       Impact factor: 17.694

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.